Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-19
2005-07-19
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253010, C514S332000, C514S339000, C514S352000, C514S646000, C546S255000, C546S273400, C546S310000, C544S106000, C544S124000, C544S333000, C544S359000, C564S319000
Reexamination Certificate
active
06919336
ABSTRACT:
Compounds of formula I and pharmaceutically-acceptable and -cleavable esters thereof and acid addition salts thereof wherein the symbols are as defined are MAP kinase inhibitors, useful pharmaceutically for treating TNFα and IL-1 mediated diseases such as rheumatoid arthritis and diseases of bone metabolism, e.g. osteoporosis.
REFERENCES:
patent: WO 9832730 (1998-07-01), None
Bhavsar et al, Man-Made Textiles in India, vol. 30, No 6, pp. 275-276, 281, 1987.
Davis Zinna Northington
Wilusz, Jr. E. Jay
LandOfFree
Hallogenated aminobenzophenones and aminobenzoylpyridines as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hallogenated aminobenzophenones and aminobenzoylpyridines as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hallogenated aminobenzophenones and aminobenzoylpyridines as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3367474